Note: Links to these online articles may no longer be active. They are provided here as a reference only. They may continue to be available via the host site's archive.
Ophthalmologist Joins Mass. Eye and Ear, Waltham
January 18, 2015 (Waltham News Tribune) - Mass. Eye and Ear recently had Dr. Nahyoung Grace Lee join our hospital in both the Waltham and Boston locations. Dr. Lee attended Johns Hopkins for her undergraduate degree and medical school, and has completed two fellowships at Mass. Eye and Ear. She will be working full time in the Ophthalmic Plastic Surgery Service, with a specialty in Asian eyelid surgery. To make an appointment with Dr. Lee, call 617-573-5550.
Tyler Ritter and Joey McIntyre
January 14, 2015 (CBS News, Sarasota, Florida) - Joey McIntyre plays Gerard McCarthy on CBS’s new show, The McCarthy’s. He is also known for New Kids on the Block, and has guest-starred in shows such as “Boston Public”, “CSI: NY” and “Psych”. McIntyre is also a huge supporter of Mass. Eye and Ear and the Curing Kids Fund. He has participated in our Sense-ation! Gala for the past few years, and we are very grateful for his support!
CT Scans Performed During Maxillofacial Surgery are Rapid
January 9, 2015 (Medical Xpress) - Dr. David Shaye and colleagues at Mass. Eye and Ear have just completed a study regarding CT scans during oral, head and neck surgery. They have determined through a retrospective study that the average time for a CT scan during surgery is very quick, only 14.8 minutes. The most experienced surgeon averaged 3.78 minutes less than that. The authors of the study “recommend surgeons consider the use of intraoperative CT imaging for maxillofacial reconstruction, particularly in complex procedures."
Two New Stem Cell Techniques and Clinical Trials for Cornea Damage
January 7, 2015 (Drug Discovery & Development) - A team of researchers, including those from Mass. Eye and Ear, have successfully regrown a human cornea in a mouse subject. They created antibodies that found the ABCB5 receptor, which is a marker for limbal stem cells. These stem cells aid in the regrowth of human corneal tissue, but their loss is common and is one of the leading causes of blindness. Natasha Frank, of Harvard Medical School, said that “ABCB5 can serve as a first biomarker for specific isolation of limbal stem cells for therapeutic transplantation”, and that these stem cells are capable of re-growing a fully-functioning human cornea. Although this has only been proven in mice so far, the team is working to meet the requirements to bring it to a clinical trial.
Blocking Notch Pathway Boosts Sensory Hair Cell Regeneration to Restore Hearing
January 3, 2015 (Science Codex) - A team of researchers from Mass. Eye and Ear and Fudan University in China have figured out that by blocking the Notch pathway, they can restore hearing. Scientists have already known that by blocking this pathway, inner ear supporting cells can be converted to hair cells that promote hearing. These researchers also discovered that blocking the Notch pathway promotes cell division. According to Dr. Zheng-Yi Chen, of Mass. Eye and Ear, “Our work could have potential in leading to developing new strategies to achieve hair cell regeneration for hearing restoration."
Panel-Based Genetic Diagnostic Testing for Inherited Eye Diseases Is Accurate, More Sensitive Than Exome Sequencing
January 1, 2015 (Advance Healthcare Network) - Mass. Eye and Ear now offers a more accurate alternative to finding genetic vision disorders. The Genetic Eye Disease, or GEDi, test is able to successfully sequence 226 genes known to cause hereditary eye disorders. It has gone through multiple trials, proving that the test is both accurate and reproducible, which is something many other tests cannot show. "The results we obtained for the GEDi test have broad implications and show that panel-based testing focused on the specific genes associated with genetic conditions offers important advantages over whole exome sequencing," says Janey Wiggs, M.D., Ph.D., of Mass. Eye and Ear. These tests can be used to preserve vision, using techniques such as specialized gene therapy. The test is offered at Mass. Eye and Ear on a CLIA-certified basis.